Virtual Event: Attend virtually from anywhere.

7th Edition of Cardiology World Conference

October 08-10, 2026 | Virtual Event

October 08 -10, 2026 | Virtual Event

Cardio 2026

Syed Raza, Speaker at Cardiovascular Conference
Keynote Presentation
Syed Raza, Awali Hospital, Bahrain

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have emerged as a cornerstone in managing type 2 diabetes (T2D) and obesity, demonstrating benefits that extend far beyond glycaemic control. Initially developed for metabolic regulation, several large-scale cardiovascular out [....] » Read More

Mekhman N Mamedov, Speaker at Cardiology Conferences
Keynote Presentation
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation

Diabetes Mellitus (DM) has become a global epidemic. Its prevalence is increasing and is becoming younger among adults. Although type 2 diabetes accounts for the majority of diabetes, type 1 diabetes is also increasing. Patients with DM often have complex coronary anatomy, compli [....] » Read More

Sekib Sokolovic, Speaker at Cardiology Conferences
Keynote Presentation
Sekib Sokolovic, ASA Hospital, Bosnia and Herzegowina

Sudden cardiac death (SCD) among athletes has been increased in recent years. This high-impact event occurs from unrecognized structural or electrical heart disease in professional athletes, while in recreational sports happens in older athletes due to occult coronary artery dise [....] » Read More

Sarsenbaeva Gulzhan, Speaker at Heart Conferences
Oral Presentation
Sarsenbaeva Gulzhan, Institute of Surgery, Kazakhstan

In domestic cardiac surgery, there is currently a trend towards an increasing incidence of complex, combined, and rare pathologies of the heart and blood vessels in children. The purpose of the report : to study rare congenital heart anomalies encountered in pediatric cardiac [....] » Read More

Rahul Hajare, Speaker at Heart Conferences
Oral Presentation
Rahul Hajare, Sandip University, India

Post COVID-19 pulmonary assessment revealed a persistent decrease in maximal oxygen consumption (VO? max) among previously symptomatic individuals. A proportion of patients particularly those with severe disease or ARDS exhibited reduced diffusion capacity for carbon monoxide (DL [....] » Read More

Burcu Yagmur, Speaker at Heart Conferences
Oral Presentation
Burcu Yagmur, Kyrenia University Hospital, Cyprus

Cardiovascular magnetic resonance (CMR) imaging provides comprehensive tissue characterization and plays a central role in the evaluation of a broad spectrum of cardiovascular diseases. Because routine CMR acquisition also includes portions of the thorax and upper abdomen, incide [....] » Read More

Burcu Yagmur, Speaker at Heart Conferences
Oral Presentation
Burcu Yagmur, Kyrenia University Hospital, Cyprus

Recurrent pericarditis (RP), historically labeled "idiopathic," is increasingly recognized as an NLRP3 inflammasome/interleukin-1 (IL-1)–driven autoinflammatory syndrome[cite: 6]. This study quantitatively synthesizes genetic-architecture and IL-1 blockade trial d [....] » Read More

Danish Malik, Speaker at Cardiovascular Conference
Oral Presentation
Danish Malik, University Hospitals Dorset NHS Foundation Trust, United Kingdom

Background: Iron deficiency is common in patients with heart failure with reduced ejection fraction (HFrEF) and is associated with worse symptoms, reduced exercise capacity, and increased hospitalisation. Contemporary guidelines recommend assessment of iron status using serum fer [....] » Read More

 Amadio Bianchi Swami Suryananda Saraswati, Speaker at Cardiology Conferences
Oral Presentation
Amadio Bianchi Swami Suryananda Saraswati, European Yoga Federation, Italy

This means that one can influence the other, both in terms of the onset of disease and its healing. It should also be kept in mind that this aspect is also important for prevention. Sometimes, it can be sufficient (given their mutual influence) to begin establishing a healthy bal [....] » Read More

 Franz Porzsolt, Speaker at Cardiovascular Conference
Oral Presentation
Franz Porzsolt, Private Research Institute Clinical Economics, Germany

The individual risk profile of the patient and the health added value of the interventions define the affordability of health care. 1. The re-allocation of resources guarantees the financial viability of healthcare. 2. Re-allocation is based on evidence of objective proof o [....] » Read More

 Amanda Tan Wei Zhen, Speaker at Heart Conferences
Oral Presentation
Amanda Tan Wei Zhen, Glangwili Hospital, United Kingdom

Valvular heart disease (VHD) remains a major and growing cause of cardiovascular morbidity and mortality, particularly in ageing populations. The recent ESC/EACTS 2025 Guidelines provide an updated, evidence-based framework for the diagnosis, risk stratification, and management o [....] » Read More

Abdul Wahed Sidiqi, Speaker at Cardiovascular Conference
Oral Presentation
Abdul Wahed Sidiqi, Afghanistan Cardiovascular Association, Afghanistan

Background: The optimal management strategy for patients with chronic stable angina (CSA) remains under debate, especially in resource-limited settings. This study compared the efficacy and safety of percutaneous coronary intervention (PCI) and optimal medical therapy (OMT) in pa [....] » Read More

Francesco Fiumara, Speaker at Cardiovascular Conference
Oral Presentation
Francesco Fiumara, John F Kennedy Medical Center, United States

Invasive hemodynamic assessment with right heart catheterization is currently indicated when the clinical assessment of volume status does not match the physiologic response to treatment, cardiogenic shock, and for the evaluation of advanced therapies such as heart transplant and [....] » Read More

 Ruth Rasmussen, Speaker at Cardiovascular Conference
Oral Presentation
Ruth Rasmussen, Liberty University, United States

Purpose: The objective of this study was to assess differences in dietary behavior and clinical risk factor outcomes and explore predictors of change among patients participating in traditional and Pritikin intensive cardiac rehabilitation (CR). Methods:  This secondary a [....] » Read More

Steve Cohen, Speaker at Cardiovascular Conference
Oral Presentation
Steve Cohen, Medvesta Hypnosis Healthcare, NSA Illinois, United States

This keynote highlights how movement as medicine supports the goals of the Cardiology World Conference 2026 by emphasizing innovative, preventive approaches to heart health. For cardiologists, cardiovascular surgeons, researchers, healthcare practitioners, academicians, industry [....] » Read More

Zarif Bin Akhtar, Speaker at Cardiovascular Conference
Oral Presentation
Zarif Bin Akhtar, Institute of Electrical and Electronics Engineers (IEEE), United States

Organoid engineering has emerged as one of the most promising frontiers in biomedical engineering, regenerative medicine, and precision healthcare. These three-dimensional (3D) in vitro tissue models faithfully recapitulate key structural and functional characteristics of native [....] » Read More

Guo Wei He, Speaker at Cardiovascular Conference
Keynote Presentation
Guo Wei He, TEDA International Cardiovascular Hospital, Tianjin University, China

Heart failure (HF) is often a result of cardiac hypertrophy, and it is still the main public health challenge. Although vericiguat has been proved to be effective in treating heart failure through soluble guanylate cyclase (sGC), its potential preventive effects on myocardial hyp [....] » Read More

James V Cireddu, Speaker at Cardiovascular Conference
Keynote Presentation
James V Cireddu, Case Western University, United States

Background: Low-dose CT attenuation-correction (CTAC) images acquired during SPECT and PET myocardial perfusion imaging are often treated primarily as technical inputs, even though they contain potentially actionable anatomic information. Coronary artery calcium (CAC), epicardial [....] » Read More

Liu Yiru, Speaker at Cardiology Conferences
Oral Presentation
Liu Yiru, Southwest Jiaotong University, China

Objective: To observe the clinical efficacy of the new technique of "acupuncture cupping blistering therapy" in treating 88 cases of angina pectoris. Methods: 88 patients with angina pectoris were randomly divided into an acupuncture cupping blistering therapy group (n= [....] » Read More

Abhishek Bansal, Speaker at Cardiovascular Conference
Oral Presentation
Abhishek Bansal, New Era Consultancy Services, India

Cardio-vascular drug testing and safety monitoring require more than isolated drug concentration, ECG interpretation, biomarker review, or conventional hemodynamic assessment. Drug response emerges through a coupled physiological environment involving cardiac anatomy, vascular ge [....] » Read More

Bijendra Singh, Speaker at Cardiovascular Conference
Oral Presentation
Bijendra Singh, Central University of Gujarat, India

Ischemic heart disease is a major cardiovascular disorder characterized by inadequate coronary perfusion, endothelial dysfunction, atherosclerotic plaque formation, thrombosis, myocardial hypoxia, and an imbalance between oxygen supply and metabolic demand. Conventional cardiovas [....] » Read More

Prashant Sakharam Bhokardankar, Speaker at Heart Conferences
Oral Presentation
Prashant Sakharam Bhokardankar, Datta Meghe Ayurvedic Medical College Hospital and Research Centre, India

The incidence of cardiovascular diseases (CVDs) has greatly risen in recent years because of environmental shifts, unhealthy diets, and changes in lifestyle. Consequently, the term "hridroga," which pertains to heart-related ailments in Ayurveda, has gained prominence. [....] » Read More

 Snehasis Bhunia, Speaker at Cardiovascular Conference
Oral Presentation
Snehasis Bhunia, Uttar Pradesh University of Medical Sciences, India

Arterial stiffness is a measure of how flexible and pliable the walls of the arteries are. It is an important indicator of cardiovascular health, as stiff arteries can lead to increased risk of developing cardiovascular diseases such as heart attack and stroke. One of the main f [....] » Read More

Andrey Belousov, Speaker at Cardiology Conferences
Oral Presentation
Andrey Belousov, Kharkiv National Medical University, Ukraine

A decrease in erythrocyte electrophoretic mobility serves as an important diagnostic marker of pathological conditions associated with impaired gas exchange, microcirculation, and tissue trophism, often leading to systemic hypoxia and deterioration of the patient's clinical s [....] » Read More

Moataz Taha Mahmoud, Speaker at Heart Conferences
Oral Presentation
Moataz Taha Mahmoud, Madinah Cardiac Center, Saudi Arabia

Background: Primary cardiac lymphomas (PCL) represent extremely rare cardiac tumors which are accompanied by poor prognosis, unless they are timely diagnosed and treated. Despite the rarity of Primary cardiac lymphomas, they should always be kept in mind in the differential diagn [....] » Read More

Maria Sofra, Speaker at Heart Conferences
Oral Presentation
Maria Sofra, Aretaieion University Hospital, Greece

INTRODUCTION: Hormonal modulation therapy is an important component of hormone receptorpositive breast cancer treatment. However, the type and duration of hormonal therapies have distinct effects on lipid profile parameters and cardiovascular disease risk. This study aimed to inv [....] » Read More

Maria Sofra, Speaker at Heart Conferences
Oral Presentation
Maria Sofra, Aretaieion University Hospital, Greece

INTRODUCTION: Cardiovascular disease remains the leading cause of morbidity and mortality in patients with end-stage renal disease (ESRD) undergoing maintenance hemodialysis. Elevated cardiac troponin and homocysteine concentrations are frequently observed in this population, ref [....] » Read More

Nuha Hasnain, Speaker at Heart Conferences
Oral Presentation
Nuha Hasnain, Royal Preston Hospital, United Kingdom

Statement of the Problem: Staphylococcus lugdunensis is an uncommon coagulase-negative staphylococcus with virulence comparable to Staphylococcus aureus. Although rare, it can cause aggressive native valve infective endocarditis, characterised by rapid valvular destruction, syste [....] » Read More

Joao Rafael De Oliveira Rocha Da Silva, Speaker at Cardiovascular Conference
Oral Presentation
Joao Rafael De Oliveira Rocha Da Silva, Connect Life Rehabilitation and Performance, Brazil

Chronic pain is associated with the leading cause of disability in the world, just as cardiovascular diseases represent the highest incidence of death in the world. Both pathologies generate a high demand for health services and represent a high global population risk. In previou [....] » Read More

Teji Dhami, Speaker at Heart Conferences
Oral Presentation
Teji Dhami, BOOST your Health and Wellness, United States

Cardiovascular disease (CVD) remains the leading cause of mortality worldwide despite significant advances in pharmacological therapies and preventive cardiology. Traditional dietary recommendations have largely relied on population-based guidelines, assuming that individuals res [....] » Read More

Sergey Suchkov, Speaker at Cardiology Conferences
Keynote Presentation
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation

A new systems approach to diseased states and wellness result in a new branch in the healthcare services, namely, Personalized and Precision Medicine (PPM). In this context, the need for innovative heart disease treatments has become critical since the diseases remain the world&r [....] » Read More

Yochai Birnbaum, Speaker at Cardiology Conferences
Keynote Presentation
Yochai Birnbaum, Baylor College of Medicine, United States

The original trials assessing the effects of thrombolytic therapy versus placebo included patients with compatible symptoms and were not restricted to patients with ST elevation. However, a meta-analysis that was published in Lancet in 1996 suggested that thrombolytic therapy red [....] » Read More

Thomas J Webster, Speaker at Cardiology Conferences
Keynote Presentation
Thomas J Webster, Brown University, United States

Nanomedicine, or the use of materials with at least one dimension less than 100 nm, has led to improved disease prevention, diagnosis, and treatment. This talk will cover recent advances in the use of nanomaterials to prevent, diagnose, and treat cardiovascular diseases. Specific [....] » Read More

Michael Anjello Jothi Rajan, Speaker at Cardiovascular Conference
Oral Presentation
Michael Anjello Jothi Rajan, AERT, India

Will be Updated Soon...

Zareena Ali, Speaker at Cardiovascular Conference
Oral Presentation
Zareena Ali, The Women University Multan, Pakistan

AMR presents a significant challenge for controlling cardiovascular infections, especially infective endocarditis (IE) since persistent bacteremia, biofilm formation and infection of cardiac valves affect conventional antimicrobial therapy. Nanoantibiotics have recently gained in [....] » Read More

Lawal Kayode Olatunji, Speaker at Heart Conferences
Oral Presentation
Lawal Kayode Olatunji, Usmanu Danfodiyo University Sokoto, Nigeria

Background: Cardiovascular diseases (CVDs) and metabolic syndrome (MetS) exhibit profound sexual dimorphism, yet many pharmacological interventions remain non-specific. While statins are the gold standard for dyslipidemia, suboptimal efficacy and side effects necessitate precisio [....] » Read More

Ermiyas Berehanu Hayle, Speaker at Cardiology Conferences
Oral Presentation
Ermiyas Berehanu Hayle, Hallelujah General Hospital, Ethiopia

Dilated cardiomyopathy (DCM) is one of the most important causes of heart failure and premature death globally, yet its burden is far from uniform. In developing nations—where diagnosis is often delayed, access to specialized cardiac care is limited, and multiple overlappin [....] » Read More

Sergey Suchkov, Speaker at Cardiology Conferences
Oral Presentation
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation

Stem cell (SC)-based therapy has been considered as a promising option in the treatment of ischemic heart disease. The formation of new cardiomyocytes within the injured myocardium has not been conclusively demonstrated. Consequently, the focus of research in the field has since [....] » Read More

Yasser Mohammed Hassanain Elsayed, Speaker at Cardiovascular Conference
Oral Presentation
Yasser Mohammed Hassanain Elsayed, Egyptian Ministry of Health, Egypt

Rationale: Diagnosis of ST-segment elevation myocardial infarction in the presence of left bundle branch block (LBBB) is challenging and infarction equivalent. Therefore, the intravenous infusion of a thrombolytic may be a crucial step. Emergent Sgarbosa criteria and their modifi [....] » Read More

Iris Panagiota Efthymiou, Speaker at Heart Conferences
Oral Presentation
Iris Panagiota Efthymiou, University of Greenwich, United Kingdom

As global populations age, geriatric cardiology faces the dual challenge of managing complex cardiovascular conditions while addressing behavioral barriers to adherence and prevention. This presentation explores the transformative role of Artificial Intelligence (AI) in integrati [....] » Read More

Lozan Hussein Mahmood Zangana, Speaker at Heart Conferences
Oral Presentation
Lozan Hussein Mahmood Zangana, University Hospitals Birmingham NHS Foundation Trust, United Kingdom

Background Venous thromboembolism (VTE) prophylaxis is an important patient-safety process in acutely admitted cardiology patients, where immobility, heart failure, myocardial infarction and invasive cardiac procedures can increase thrombotic risk while complex antithrombotic [....] » Read More

Moganapriya, Speaker at Heart Conferences
Poster Presentation
Moganapriya, Tan Tock Seng Hospital, Singapore

A 36-year-old woman with a significant history of Group 1 pulmonary arterial hypertension (PAH) with secondary to mixed connective tissue disease overlap syndrome (systemic lupus erythematosus and systemic sclerosis), presented with a one-week history of fever, nonproductive c [....] » Read More

 Davor Horvat, Speaker at Heart Conferences
Poster Presentation
Davor Horvat, General Hospital, Croatia (Hrvatska)

In our review, we wanted to highlight the advantages of implanting cardiac pacemakers on the right side of the chest, with the generator site below the right clavicle. This approach is not used as often as a method of implanting cardiac pacemakers today, but it has its advantages [....] » Read More

Junaid Naeem, Speaker at Cardiology Conferences
Poster Presentation
Junaid Naeem, Manchester University NHS Foundation Trust, United Kingdom

Background: Acute coronary syndrome (ACS) in young adults is uncommon and should prompt consideration of non-atherosclerotic causes of coronary artery disease. Kawasaki disease (KD) is a childhood vasculitis associated with late coronary complications, including aneurysm formati [....] » Read More

Mihye Lee, Speaker at Heart Conferences
Poster Presentation
Mihye Lee, Bournemouth University, United Kingdom

Artificial intelligence (AI) and machine learning (ML) are increasingly being used for infective endocarditis (IE) conditions, particularly for their diagnosis and prognosis with predictive modelling. This will lead to medical reporting greater improvements in diagnostic accuracy [....] » Read More

Eric Tran, Speaker at Cardiovascular Conference
Poster Presentation
Eric Tran, University of California - Riverside, United States

Background: Takotsubo cardiomyopathy (TCM) is a state of left ventricular (LV) dysfunction induced by a hypercatecholaminergic milieu, leading classically to apical dyskinesis with a compensatory hyperdynamic base. We present a case of sepsis-induced TCM complicated by torsades d [....] » Read More

Eric Tran, Speaker at Cardiovascular Conference
Poster Presentation
Eric Tran, University of California - Riverside, United States

Background: Pulmonary vein isolation (PVI) is the cornerstone of catheter ablation for AF and is dependent on achieving durable electrical isolation of all pulmonary veins (PVs). Anatomical variations, such accessory PVs, are common and can lead to incomplete isolation and arrhyt [....] » Read More

Zin Thandar Win, Speaker at Cardiovascular Conference
Poster Presentation
Zin Thandar Win, University of California, United States

Background: Thyrotoxic periodic paralysis (TPP) is a rare but potentially fatal manifestation of hyperthyroidism characterized by sudden hypokalemic paralysis. Excess thyroid hormone stimulates the Na?/K?-ATPase pump, causing rapid intracellular potassium shifts and severe hypok [....] » Read More

Whatsapp